NEW YORK, Feb. 7 - Orchid BioSciences and a unit of Thermo Electron have signed a series of technology agreements to develop and market SNP-based diagnostic tests for point-of-care applications and genotyping products for research.

Terms of the agreements call for Orchid to receive non-exclusive rights from Thermo Electron's Thermo BioStar business to develop, supply, and sell genotyping products that will combine Orchid's SNP-IT genotyping technology with BioStar's OIA biosensor technologies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.